Cargando…

A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD

BACKGROUND: Skeletal muscle impairment is a recognized complication of COPD, predicting mortality in severe disease. Increasing evidence implicates the renin-angiotensin system in control of muscle phenotype. We hypothesized that angiotensin-converting enzyme (ACE) inhibition would improve quadricep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrikrishna, Dinesh, Tanner, Rebecca J., Lee, Jen Y., Natanek, Amanda, Lewis, Amy, Murphy, Patrick B., Hart, Nicholas, Moxham, John, Montgomery, Hugh E., Kemp, Paul R., Polkey, Michael I., Hopkinson, Nicholas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188149/ https://www.ncbi.nlm.nih.gov/pubmed/24556825 http://dx.doi.org/10.1378/chest.13-2483

Ejemplares similares

Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD
por: Maddocks, Matthew, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
por: Lewis, Amy, et al.
Publicado: (2011)

ACE and response to pulmonary rehabilitation in COPD: two observational studies
por: Kon, Samantha S C, et al.
Publicado: (2017)

MuRF-1 and Atrogin-1 Protein Expression and Quadriceps Fiber Size and Muscle Mass in Stable Patients with COPD
por: Natanek, Samantha A., et al.
Publicado: (2013)

Lung function indices for predicting mortality in COPD
por: Boutou, Afroditi K., et al.
Publicado: (2013)

Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV
por: Nickol, Annabel H, et al.
Publicado: (2008)

Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure
por: Hosseini-khalili, Ali Reza, et al.
Publicado: (2008)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Reduced HDAC2 in skeletal muscle of COPD patients
por: To, Masako, et al.
Publicado: (2017)

Increased expression of H19/miR‐675 is associated with a low fat‐free mass index in patients with COPD
por: Lewis, Amy, et al.
Publicado: (2016)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease
por: Hopkinson, Nicholas S, et al.
Publicado: (2010)

A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease
por: Hopkinson, Nicholas S, et al.
Publicado: (2007)

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study
por: Connolly, Bronwen A, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
por: Kakutani, Naoya, et al.
Publicado: (2020)

Quadriceps miR-542-3p and -5p are elevated in COPD and reduce function by inhibiting ribosomal and protein synthesis
por: Farre-Garros, Roser, et al.
Publicado: (2019)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Determinants of circulating angiotensin-converting enzyme 2 protein levels in the general population
por: Kuznetsova, Tatiana, et al.
Publicado: (2021)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life Span
por: Kumar, Sandeep, et al.
Publicado: (2016)

The effect of acute non-invasive ventilation on corticospinal pathways to the respiratory muscles in chronic obstructive pulmonary disease
por: Hopkinson, Nicholas S., et al.
Publicado: (2012)

Influenza vaccination for NHS staff: attitudes and uptake
por: Shrikrishna, Dinesh, et al.
Publicado: (2015)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Acute Dietary Nitrate Supplementation and Exercise Performance in COPD: A Double-Blind, Placebo-Controlled, Randomised Controlled Pilot Study
por: Curtis, Katrina J., et al.
Publicado: (2015)

Skeletal muscle strength in critically ill patients
por: Harris, ML, et al.
Publicado: (1999)

Imaging Review of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema of the Head and Neck
por: Baig, Saif, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-I-converting enzyme and its relatives
por: Riordan, James F
Publicado: (2003)

Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dgeghgr0c4b0m1hp6ks1v73b9d